Question · asked by 1 review
Anticoagulant drugs: VKA high dose vs vitamin K antagonist (VKA): Adverse events
- Population
- people with antiphospholipid syndrome and a history of stroke or thromboembolic events
- Intervention
- Anticoagulant drugs: VKA high dose
- Comparison
- vitamin K antagonist (VKA)
- Outcome
- Adverse events
The review found no eligible studies for this question.
What each review found
Current versions onlyNo studies found 2 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
High‐dose VKA vs standard‐dose VKA Adverse events · people with antiphospholipid syndrome and a history of stroke or thromboembolic events The review found no eligible studies for this question. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in… (2020) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Anticoagulant drugs: VKA high dose vs standard VKA therapy Adverse events · people with antiphospholipid syndrome and a history of stroke or thromboembolic events The review found no eligible studies for this question. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in… (2017) · Cochrane Headline outcomes onlyearlier version CD012169.PUB2, superseded | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid… 2020 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.